Aier Eye Hospital Group proposes 2025 interim dividend, board re-election

Aier Eye Hospital Group announced an interim cash dividend of 0.8 yuan per 10 shares (including tax) for 2025, totaling 743,522,679.36 yuan. This is based on 9,294,033,492 shares, after excluding repurchased shares, and aligns with the company's strong financial performance, with net profits attributable to the parent company reaching 3,114,740,426.82 yuan as of September 30, 2025. This proposal is subject to shareholder approval at the upcoming 2025 third extraordinary general meeting on November 27, 2025.

In addition to the dividend, the company also proposed the re-election of its board of directors, with seven candidates nominated for the seventh board term. These include three non-independent directors (Mr. Chen Bang, Mr. Li Li, Mr. Wu Shijun) and three independent directors (Mr. Gao Guolei, Ms. Liu Duan, Mr. Tian Suhua). These nominations, along with amendments to the company's articles of association and various internal control policies, will be voted on at the general meeting.

The proposed amendments cover internal controls, fundraising management, and information disclosure to align with new regulations. These comprehensive updates underscore Aier Eye Hospital Group's commitment to enhancing corporate governance, investor returns, and operational efficiency, ensuring compliance and long-term sustainable development.